Literature DB >> 32469633

What We Need to Consider During and After the SARS-CoV-2 Pandemic.

Willy A Valdivia-Granda1, Jürgen A Richt2,3.   

Abstract

Even though extreme containment and mitigation strategies were implemented by numerous governments around the world to slow down the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the number of critically ill patients and fatalities keeps rising. This crisis has highlighted the socioeconomic disparities of health care systems within and among countries. As new CoVID policies and responses are implemented to lessen the impact of the virus, it is imperative (1) to consider additional mitigation strategies critical for the development of effective countermeasures, (2) to promote long-term policies and strict regulations of the trade of wildlife and live animal markets, and (3) to advocate for necessary funding and investments in global health, specifically for the prevention of and response to natural and manmade pandemics. This document considers some of these challenges.

Entities:  

Keywords:  CoVID-19; SARS-CoV-2; biodefense; pandemic

Mesh:

Substances:

Year:  2020        PMID: 32469633      PMCID: PMC7336884          DOI: 10.1089/vbz.2020.2652

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  57 in total

1.  2019 Novel Coronavirus Is Undergoing Active Recombination.

Authors:  Huiguang Yi
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

Review 2.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

3.  Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.

Authors:  Chien-Te Tseng; Elena Sbrana; Naoko Iwata-Yoshikawa; Patrick C Newman; Tania Garron; Robert L Atmar; Clarence J Peters; Robert B Couch
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

4.  Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.

Authors:  Damon Deming; Timothy Sheahan; Mark Heise; Boyd Yount; Nancy Davis; Amy Sims; Mehul Suthar; Jack Harkema; Alan Whitmore; Raymond Pickles; Ande West; Eric Donaldson; Kristopher Curtis; Robert Johnston; Ralph Baric
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

Review 5.  Human Coronaviruses: A Review of Virus-Host Interactions.

Authors:  Yvonne Xinyi Lim; Yan Ling Ng; James P Tam; Ding Xiang Liu
Journal:  Diseases       Date:  2016-07-25

6.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

7.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

8.  A Bat-Derived Putative Cross-Family Recombinant Coronavirus with a Reovirus Gene.

Authors:  Canping Huang; William J Liu; Wen Xu; Tao Jin; Yingze Zhao; Jingdong Song; Yi Shi; Wei Ji; Hao Jia; Yongming Zhou; Honghua Wen; Honglan Zhao; Huaxing Liu; Hong Li; Qihui Wang; Ying Wu; Liang Wang; Di Liu; Guang Liu; Hongjie Yu; Edward C Holmes; Lin Lu; George F Gao
Journal:  PLoS Pathog       Date:  2016-09-27       Impact factor: 6.823

9.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.

Authors:  Zhi-Yong Yang; Wing-Pui Kong; Yue Huang; Anjeanette Roberts; Brian R Murphy; Kanta Subbarao; Gary J Nabel
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

10.  Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2.

Authors:  Saif Ur Rehman; Laiba Shafique; Awais Ihsan; Qingyou Liu
Journal:  Pathogens       Date:  2020-03-23
View more
  3 in total

Review 1.  Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals.

Authors:  David A Meekins; Natasha N Gaudreault; Juergen A Richt
Journal:  Viruses       Date:  2021-10-04       Impact factor: 5.048

Review 2.  Microarray patches enable the development of skin-targeted vaccines against COVID-19.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Tina L Sumpter; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Adv Drug Deliv Rev       Date:  2021-02-02       Impact factor: 17.873

3.  Known and Unknown Transboundary Infectious Diseases as Hybrid Threats.

Authors:  Willy A Valdivia-Granda
Journal:  Front Public Health       Date:  2021-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.